Abstract
The field of intracrine physiology attempts to codify the biological actions of intracrines—extracellular signaling proteins or peptides that also operate in the intracellular space, either because they are retained in their cells of synthesis or because they have been internalized by a target cell. Intracrines are structurally diverse; hormones, growth factors, DNA-binding proteins and enzymes can all display intracrine functionality. Here, we review the role of intracrines in the heart and vasculature, including the intracrine actions of renin–angiotensin-system components in cardiac pathology, dynorphin B in cardiac development, and a variety of factors in pathologic and therapeutic angiogenesis. We argue that principles of intracrine physiology can inform our understanding of important pathologic processes such as left ventricular hypertrophy, diabetic cardiomyopathy and arrythmogenesis, and can aid the development of more-effective therapeutic interventions in cardiovascular disease.
Key Points
-
The term 'intracrine' refers to the intracellular action of an extracellular signaling peptide
-
Intracrine factors are structurally diverse and include hormones, growth factors, DNA-binding proteins, enzymes, and other factors
-
Intracrines seem to form regulatory loops, which result in cell differentiation, altered hormonal responsiveness, and establishment of cellular memory
-
Recent results indicate that angiotensin II, renin and dynorphin can act in an intracrine fashion in cardiac myocytes
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Re RN and Cook JL (2005) The intracrine hypothesis: an update. Regul Pept 133: 1–9
Gobeil F et al. (2006) G-protein-coupled receptors signalling at the cell nucleus: an emerging paradigm. Can J Physiol Pharmacol 84: 287–297
Re RN and Cook JL (2006) An intracrine view of angiogenesis. Bioessays 28: 943–953
Robertson AL Jr and Khairallah PA (1971) Angiotensin II: rapid localization in nuclei of smooth and cardiac muscle. Science 172: 1138–1139
Re RN et al. (1981) Specific nuclear binding of angiotensin II. Clin Sci 61: 245s–247s
Re RN (1982) Changes in nuclear initiation sites after the treatment of isolated nuclei with angiotensin II. Clin Sci 63: 191s–193s
Re RN and Parab M (1984) Effect of angiotensin II on RNA synthesis by isolated nuclei. Life Sci 34: 647–651
Booz GW et al. (1992) Angiotensin-II-binding sites on hepatocyte nuclei. Endocrinology 130: 3641–3649
Tang SS et al. (1992) Characterization of nuclear angiotensin-II binding sites in rat liver and comparison with plasma membrane receptors. Endocrinology 131: 374–380
Eggena P et al. (1996) Hepatic angiotensin II nuclear receptors and transcription of growth-related factors. J Hypertens 14: 961–968
Erdmann B et al. (1996) Subcellular localization of angiotensin II immunoreactivity in the rat cerebellar cortex. Hypertension 28: 818–824
Lu D et al. (1998) Angiotensin II-induced nuclear targeting of the angiotensin type 1 (AT1) receptor in brain neurons. Endocrinology 139: 365–375
Chen R et al. (2000) A functional angiotensin II receptor-GFP fusion protein: evidence for agonist-dependent nuclear translocation. Am J Physiol Renal Physiol 279: F440–F448
Cook JL et al. (2001) In vitro evidence for an intracellular site of angiotensin action. Circ Res 89: 1138–1146
Cook JL et al. (2002) Intracellular angiotensin II increases the long isoform of PDGF mRNA in rat hepatoma cells. J Cell Mol Cardiol 34: 1525–1537
Cook JL et al. (2006) Nuclear accumulation of the AT(1) receptor in a rat vascular smooth muscle cell line: effects upon signal transduction and cellular proliferation. J Mol Cell Cardiol 40: 696–707
Cook JL et al. (2004) Intracellular angiotensin II fusion protein alters AT1 receptor fusion protein distribution and activates CREB. J Mol Cell Cardiol 36: 75–90
Baker KM et al. (2004) Evidence of a novel intracrine mechanism in angiotensin II-induced cardiac hypertrophy. Regul Pept 120: 5–13
Baker KM and Kumar R (2006) Intracellular angiotensin ii induces cell proliferation independent of at1 receptor. Am J Physiol Cell Physiol 291: C995–C1001
De Mello WC (1995) Influence of intracellular renin on heart cell communication. Hypertension 25: 1172–1177
De Mello WC (1996) Renin-angiotensin system and cell communication in the failing heart. Hypertension 27: 1267–1272
De Mello WC (1998) Intracellular angiotensin II regulates the inward calcium current in cardiac myocyte. Hypertension 32: 976–982
De Mello WC (2003) Further studies on the effect of intracellular angiotensins on heart cell communication: on the role of endogenous angiotensin II. Regul Pept 115: 31–36
De Mello WC and Monterrubio J (2004) Intracellular and extracellular angiotensin II enhance the L-type calcium current in the failing heart. Hypertension 44: 360–364
De Mello WC (2006) Renin increments the inward calcium current in the failing heart. J Hypertens 24: 1181–1186
Haller H et al. (1999) Intracellular actions of angiotensin II in vascular smooth muscle cells. J Am Soc Nephrol 10 (Suppl 11): S75–S83
Clausmeyer S et al. (2000) Tissue-specific expression of a rat renin transcript lacking the coding sequence for the prefragment and its stimulation by myocardial infarction. Endocrinology 141: 2963–2970
Lavoie JL et al. (2006) Evidence supporting a functional role for intracellular renin in the brain. Hypertension 47: 461–466
Stubbs AJ and Skinner SL (2004) Lectin chromatography of extrarenal renin protein in human plasma and tissues: potential endocrine function via the renin receptor. J Renin Angiotensin Aldosterone Syst 5: 189–196
Peters J et al. (2002) Functional significance of prorenin internalization in the rat heart. Circ Res 90: 1135–1141
van den Eijnden MM et al. (2001) Prorenin accumulation and activation in human endothelial cells: importance of mannose 6-phosphate receptors. Arterioscler Thromb Vasc Biol 21: 911–916
Nguyen G (2006) Renin/prorenin receptors. Kidney Int 69: 1503–1506
Sherrod M et al. (2005) Nuclear localization of angiotensinogen in astrocytes. Am J Physiol Regul Integr Comp Physiol 288: R539–R546
Tewksbury DA et al. (2003) Detection of a receptor for angiotensinogen on placental cells. Am J Hypertens 16: 59–62
Pan N et al. (2006) Specific receptor for angiotensinogen on human renal cells. Clin Chim Acta 373: 32–36
Bouquet C et al. (2006) Suppression of angiogenesis, tumor growth, and metastasis by adenovirus-mediated gene transfer of human angiotensinogen. Mol Ther 14: 175–182
Camargo de Andrade MC et al. (2006) Expression and localization of N-domain Ang I-converting enzymes (ACE) in mesangial cells in culture from spontaneously hypertensive rats (SHR). Am J Physiol Renal Physiol 290: F364–F375
Ignjacev-Lazich I et al. (2004) Angiotensin-converting enzyme regulates bradykinin receptor gene expression. Am J Physiol Heart Circ Physiol 289: H1814–H1820
Kintscher U and Unger T (2005) Vascular protection in diabetes: a pharmacological view of angiotensin II type 1 receptor blockers. Acta Diabetol 42 (Suppl 1): S26–S32
Re RN (2004) Mechanisms of disease: local renin-angiotensin-aldosterone systems and the pathogenesis and treatment of cardiovascular disease. Nat Clin Pract Cardiovasc Med 1: 42–47
Ducharme A et al; CHARM Investigators (2006) Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. Am Heart J 152: 86–92
Re R (1999) The nature of intracrine peptide hormone action. Hypertension 34: 534–538
Re RN (2003) Intracellular renin and the nature of intracrine enzymes. Hypertension 42: 117–122
Massfelder T et al. (1997) Opposing mitogenic and anti-mitogenic actions of parathyroid hormone-related protein in vascular smooth muscle cells: a critical role for nuclear targeting. Proc Natl Acad Sci USA 94: 13630–13635
Bonnet H et al. (1996) Fibroblast growth factor-2 binds to the regulatory beta subunit of CK2 and directly stimulates CK2 activity toward nucleolin. J Biol Chem 271: 24781–24787
Kishimoto K et al. (2005) Endogenous angiogenin in endothelial cells is a general requirement for cell proliferation and angiogenesis. Oncogene 24: 445–456
Gerber HP et al. (2002) VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism. Nature 417: 954–958
Nijholt I et al. (2004) Stress-induced alternative splicing of acetylcholinesterase results in enhanced fear memory and long-term potentiation. Mol Psychiatry 9: 174–183
Grisaru D et al. (2001) ARP, a peptide derived from the stress-associated acetylcholinesterase variant, has hematopoietic growth promoting activities. Mol Med 7: 93–105
Ventura C and Branzi A (2006) Autocrine and intracrine signaling for cardiogenesis in embryonic stem cells: a clue for the development of novel differentiating agents. Handb Exp Pharmacol 174: 123–146
Ventura C et al. (1994) Dynorphin gene expression and release in the myocardial cell. J Biol Chem 269: 5384–5386
Ventura C et al. (1998) Nuclear opioid receptors activate opioid gene transcription in isolated myocardial nuclei. J Biol Chem 273: 13383–13386
Ventura C et al. (2003) Protein kinase C signaling transduces endorphin-primed cardiogenesis in GTR1 embryonic stem cells. Circ Res 92: 623–629
Ventura C et al. (2003) Dynorphin B is an agonist of nuclear opioid receptors coupling nuclear protein kinase C activation to the transcription of cardiogenic genes in GTR1 embryonic stem cells. Circ Res 92: 623–629
O'Brien ER et al. (1994) Angiogenesis in human coronary atherosclerotic plaques. Am J Pathol 145: 883–894
Reilly JP et al. (2005) Long-term (2-year) clinical events following transthoracic intramyocardial gene transfer of VEGF-2 in no-option patients. J Interv Cardiol 18: 27–31
Narizhneva NV et al. (2005) Thrombospondin-1 up-regulates expression of cell adhesion molecules and promotes monocyte binding to endothelium. FASEB J 19: 1158–1160
Tringler B et al. (2005) Immunohistochemical expression of thrombospondin-1 in invasive vulvar squamous cell carcinoma. Gynecol Oncol 99: 80–83
Kishimoto K et al. (2005) Endogenous angiogenin in endothelial cells is a general requirement for cell proliferation and angiogenesis. Oncogene 24: 445–456
Deng JS et al. (1996) Internalization of anti-nucleolin antibody into viable HEp-2 cells. Mol Biol Rep 23: 191–195
Joo EJ et al. (2005) Nucleolin: acharan sulfate-binding protein on the surface of cancer cells. Glycobiology 15: 1–9
Alghisi GC and Ruegg C (2006) Vascular integrins in tumor angiogenesis: mediators and therapeutic targets. Endothelium 13: 113–135
Ashton AW et al. (2004) Thromboxane A2 receptor agonists antagonize the proangiogenic effects of fibroblast growth factor-2: role of receptor internalization, thrombospondin-1, and alpha(v)beta3. Circ Res 94: 735–742
Calzada MJ and Roberts DD (2005) Novel integrin antagonists derived from thrombospondins. Curr Pharm Des 11: 849–866
Tarui T et al. (2001) Specific interaction of angiostatin with integrin alpha(v)beta(3) in endothelial cells. J Biol Chem 276: 39562–39568
Escuin D et al. (2005) Both microtubule-stabilizing and microtubule-destabilizing drugs inhibit hypoxia-inducible factor-1alpha accumulation and activity by disrupting microtubule function. Cancer Res 65: 9021–9028
Stafford SJ et al. (2005) Colchicine and 2-methoxyestradiol inhibit human angiogenesis. J Surg Res 125: 104–108
Roiz L et al. (2006) ACTIBIND, an actin-binding fungal T(2)-RNase with antiangiogenic and anticarcinogenic characteristics. Cancer 106: 2295–2308
Hirukawa S et al.(2005) Neamine inhibits xenografic human tumor growth and angiogenesis in athymic mice. Clin Cancer Res 11: 8745–8752
Singh VP et al. (2007) High glucose induced regulation of intracellular angiotensin ii synthesis and nuclear redistribution in cardiac myocytes. Am J Physiol Heart Circ Physiol [doi:10.1152/ajpheart.00391.2007]
Re RN and Cook JL (2007) Potential therapeutic implications of intracrine angiogenesis. Med Hypotheses 69: 414–421
Cook JL et al. (2006) Cleavage of the angiotensin AT1 receptor and nuclear accumulation of the cytoplasmic carboxy-terminal fragment. Am J Physiol Cell Physiol 292: C1313–C1322
Patberg KW et al. (2003) Cardiac memory is associated with decreased levels of the transcriptional factor CREB modulated by angiotensin II and calcium. Circ Res 93: 472–478
Limana F et al. (2005) Exogenous high-mobility group Box 1 protein induces myocardial regeneration after infarction via enhanced cardiac C-kit+ cell proliferation and differentiation. Circ Res 97: e73–e83
Saris JJ et al. (2006) Prorenin induces intracellular signaling in cardiomyocytes independently of angiotensin II. Hypertension 48: 564–571
Schefe JH et al. (2006) A novel signal transduction cascade involving direct physical interaction of the renin/prorenin receptor with the transcription factor promyelocytic zinc finger protein. Circ Res 99: 1355–1366
Fiordaliso F et al. (2000) Myocyte death in streptozotocin-induced diabetes in rats in angiotensin II-dependent. Lab Invest 80: 513–527
Frustaci A et al. (2000) Myocardial cell death in human diabetes. Circ Res 87: 1123–1132
Chen Y et al. (2001) Nuclear translocation of PDCD5 (TFAR19): an early signal for apoptosis? FEBS Lett 509: 191–196
Lindahl E et al. (2007) Cellular internalization of proinsulin C-peptide. Cell Mol Life Sci 64: 479–486
Acknowledgements
This study was funded by the Ochsner Clinic Foundation and by National Heart, Lung, and Blood Institute grant HL072795.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Re, R., Cook, J. Mechanisms of Disease: intracrine physiology in the cardiovascular system. Nat Rev Cardiol 4, 549–557 (2007). https://doi.org/10.1038/ncpcardio0985
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncpcardio0985